REGENERON PHARMACEUTICALS, INC. (REGN)
Clinical trial NCT06787612 updates: 1. completion date: 2028-10-30 → 2028-06-30 2. primary completion date: 2028-10-30 → 2028-06-30 3. enrollment: 220 → 297 participants
Clinical trial NCT06787612 updates: 1. completion date: 2028-10-30 → 2028-06-30 2. primary completion date: 2028-10-30 → 2028-06-30 3. enrollment: 220 → 297 participants
📉 **NEGATIVE** • Medium confidence analysis (68%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical